Results 1 to 10 of about 52,816 (194)

A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption [PDF]

open access: yesMedicina, 2021
Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the onset of rash at a fixed location on the body each time a specific medication is ingested. With each recurrence, the eruption can involve additional sites.
Hannah J. Anderson, Jason B. Lee
doaj   +3 more sources

Generalized fixed drug eruption following Pfizer‐BioNtech COVID‐19 vaccination [PDF]

open access: yesClinical Case Reports, 2022
Fixed drug eruption is a cutaneous drug reaction which recurs at the same site when the individual is exposed to the causative drug, characterized by single or multiple round sharply demarcated erythematous‐to‐violaceous patches.
Soodeh Kabir   +2 more
doaj   +3 more sources

Galcanezumab-induced fixed drug eruption [PDF]

open access: goldJAAD Case Reports, 2021
Skylar Klager, SM   +3 more
doaj   +3 more sources

Fixed Drug Eruption Caused by Garenoxacin: A Case Report and Literature Review. [PDF]

open access: yesCureus, 2023
A new quinolone antibiotic called garenoxacin was developed in Japan. Garenoxacin is known to produce cutaneous adverse effects, particularly fixed drug eruption in Japan, despite several reports of cutaneous adverse events in English-language literature.
Hara N, Saito-Sasaki N, Sawada Y.
europepmc   +2 more sources

Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis. [PDF]

open access: yesFront Med (Lausanne), 2023
Generalized bullous fixed drug eruption (GBFDE) is the most severe form of fixed drug eruption and can be misdiagnosed as epidermal necrolysis (EN). We report the case of a 42-year-old male patient presenting with more than 50% skin detachment without ...
Paulmann M   +3 more
europepmc   +2 more sources

Fixed drug eruption. [PDF]

open access: yesCMAJ, 2022
CMAJ | August 2, 2022 | Volume 194 | Issue 29 © 2022 CMA Impact Inc. or its licensors A 31-year-old woman presented to the dermatology department with an asymptomatic erythematous patch on the dorsum of her right foot (Figure 1A). She had taken 1 dose of
Chou YJ, Chang HC.
europepmc   +2 more sources

Nimesulide-Induced Fixed Drug Eruption Followed by Etoricoxib-Induced Fixed Drug Eruption: An Unusual Case Report and Review of the Literature. [PDF]

open access: yesJ Clin Med
Fixed drug eruption (FDE) is a well-recognized, non-immediate, drug hypersensitivity reaction, often attributed to the use of various medications, most commonly non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics.
Makris M   +4 more
europepmc   +2 more sources

Hypopigmented penile fixed drug eruption [PDF]

open access: yesClinical Case Reports, 2022
Fixed drug eruptions (FDE) are typically associated with residual hyperpigmentation or non‐pigmenting lesions. There is no distinctive histopathological feature; though, drug provocation tests (DPT) can be confirmatory within 7 days.
Perpetua U. Ibekwe   +5 more
doaj   +2 more sources

Fixed drug eruption resulting from fluconazole use: a case report [PDF]

open access: goldJournal of Medical Case Reports, 2009
Introduction Fluconazole is a widely used antifungal agent with a possible side effect of fixed drug eruption. However, this adverse drug effect is absent from the reported list of possible side effects of fluconazole.
Tavallaee Mahkam, Rad Mahnaz Mahmoudi
doaj   +2 more sources

Cross-Reactivity: a Case of Paracetamol-Induced Generalized Bullous Fixed Drug Eruption Followed by Dipyrone-Induced Fixed Drug Eruption [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Yuanyuan Wang,1,* Huan Xue,2,* Hejun Dai,1 Lianjuan Yang1 1Department of Medical Mycology, Center of Infectious Skin Diseases, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China; 2Department
Wang Y, Xue H, Dai H, Yang L
doaj   +2 more sources

Home - About - Disclaimer - Privacy